Cargando…

Catecholaminergic modulation of the cost of cognitive control in healthy older adults

Catecholamines have long been associated with cognitive control and value-based decision-making. More recently, we have shown that catecholamines also modulate value-based decision-making about whether or not to engage in cognitive control. Yet it is unclear whether catecholamines influence these de...

Descripción completa

Detalles Bibliográficos
Autores principales: Froböse, Monja I., Westbrook, Andrew, Bloemendaal, Mirjam, Aarts, Esther, Cools, Roshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034873/
https://www.ncbi.nlm.nih.gov/pubmed/32084218
http://dx.doi.org/10.1371/journal.pone.0229294
_version_ 1783499960482791424
author Froböse, Monja I.
Westbrook, Andrew
Bloemendaal, Mirjam
Aarts, Esther
Cools, Roshan
author_facet Froböse, Monja I.
Westbrook, Andrew
Bloemendaal, Mirjam
Aarts, Esther
Cools, Roshan
author_sort Froböse, Monja I.
collection PubMed
description Catecholamines have long been associated with cognitive control and value-based decision-making. More recently, we have shown that catecholamines also modulate value-based decision-making about whether or not to engage in cognitive control. Yet it is unclear whether catecholamines influence these decisions by altering the subjective value of control. Thus, we tested whether tyrosine, a catecholamine precursor altered the subjective value of performing a demanding working memory task among healthy older adults (60–75 years). Contrary to our prediction, tyrosine administration did not significantly increase the subjective value of conducting an N-back task for reward, as a main effect. Instead, in line with our previous study, exploratory analyses indicated that drug effects varied as a function of participants’ trait impulsivity scores. Specifically, tyrosine increased the subjective value of conducting an N-back task in low impulsive participants, while reducing its value in more impulsive participants. One implication of these findings is that the over-the-counter tyrosine supplements may be accompanied by an undermining effect on the motivation to perform demanding cognitive tasks, at least in certain older adults. Taken together, these findings indicate that catecholamines can alter cognitive control by modulating motivation (rather than just the ability) to exert cognitive control.
format Online
Article
Text
id pubmed-7034873
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70348732020-02-27 Catecholaminergic modulation of the cost of cognitive control in healthy older adults Froböse, Monja I. Westbrook, Andrew Bloemendaal, Mirjam Aarts, Esther Cools, Roshan PLoS One Research Article Catecholamines have long been associated with cognitive control and value-based decision-making. More recently, we have shown that catecholamines also modulate value-based decision-making about whether or not to engage in cognitive control. Yet it is unclear whether catecholamines influence these decisions by altering the subjective value of control. Thus, we tested whether tyrosine, a catecholamine precursor altered the subjective value of performing a demanding working memory task among healthy older adults (60–75 years). Contrary to our prediction, tyrosine administration did not significantly increase the subjective value of conducting an N-back task for reward, as a main effect. Instead, in line with our previous study, exploratory analyses indicated that drug effects varied as a function of participants’ trait impulsivity scores. Specifically, tyrosine increased the subjective value of conducting an N-back task in low impulsive participants, while reducing its value in more impulsive participants. One implication of these findings is that the over-the-counter tyrosine supplements may be accompanied by an undermining effect on the motivation to perform demanding cognitive tasks, at least in certain older adults. Taken together, these findings indicate that catecholamines can alter cognitive control by modulating motivation (rather than just the ability) to exert cognitive control. Public Library of Science 2020-02-21 /pmc/articles/PMC7034873/ /pubmed/32084218 http://dx.doi.org/10.1371/journal.pone.0229294 Text en © 2020 Froböse et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Froböse, Monja I.
Westbrook, Andrew
Bloemendaal, Mirjam
Aarts, Esther
Cools, Roshan
Catecholaminergic modulation of the cost of cognitive control in healthy older adults
title Catecholaminergic modulation of the cost of cognitive control in healthy older adults
title_full Catecholaminergic modulation of the cost of cognitive control in healthy older adults
title_fullStr Catecholaminergic modulation of the cost of cognitive control in healthy older adults
title_full_unstemmed Catecholaminergic modulation of the cost of cognitive control in healthy older adults
title_short Catecholaminergic modulation of the cost of cognitive control in healthy older adults
title_sort catecholaminergic modulation of the cost of cognitive control in healthy older adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034873/
https://www.ncbi.nlm.nih.gov/pubmed/32084218
http://dx.doi.org/10.1371/journal.pone.0229294
work_keys_str_mv AT frobosemonjai catecholaminergicmodulationofthecostofcognitivecontrolinhealthyolderadults
AT westbrookandrew catecholaminergicmodulationofthecostofcognitivecontrolinhealthyolderadults
AT bloemendaalmirjam catecholaminergicmodulationofthecostofcognitivecontrolinhealthyolderadults
AT aartsesther catecholaminergicmodulationofthecostofcognitivecontrolinhealthyolderadults
AT coolsroshan catecholaminergicmodulationofthecostofcognitivecontrolinhealthyolderadults